Tuesday, July 7, 2015

No Supreme Court decision yet on Mutual Pharmaceutical Co., v. Bartlett

The U.S. Supreme Court issued three decisions Thursday, but none of them were the case involving Philadelphia's Mutual Pharmaceutical Co.

No Supreme Court decision yet on Mutual Pharmaceutical Co., v. Bartlett

0 comments
The U.S. Supreme Court.  (Charles Dharapak / Associated Press, File)
The U.S. Supreme Court. (Charles Dharapak / Associated Press, File)
Travel Deals

The U.S. Supreme Court issued three decisions Thursday, but none of them were Mutual Pharmaceutical Co., v. Bartlett, 12-142.

Mutual used to be a private, stand-alone Philadelphia company, founded in 1947. But since the case began, it was sold to Takeda Pharmaceuticals and then Sun Pharmaceuticals, so Sun inherits the ligation. The case involves whether federal law regarding FDA rules supersede a patient's ability to sue a generic drug company for product design in state court. A New Hampshire woman, Karen Bartlett, suffered a horrible reaction to a generic drug made by Mutual.

A previous Inquirer story, in advance of oral arguments, is here.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter